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Syngeneic  monoclonal  nti-idiotope  antibody 
Ab2.2-17C3SCC  was  raised  against an  idiotope on a 
protective  monoclonal  antibody with specificity  for 
poliovirus  type 11. Ab2.2-17C3SCC detects a para- 
tope-related  interspecies I d x .  Ab2.2-17C3SCC  puri- 
fied  from  supernatant  fluids  of  hybridoma cells by 
protein  A-Sepharose  was  injected  into 4- to 6-wk- 
old  BALB/c mice.  The  sera of the  mice  were  screened 
for the  expression of antibodies  bearing  the  corre- 
sponding  idiotope.  Immunization of mice  with 
Ab2.2-17C3SCC  induced  antibodies of complemen- 
tary  specificity.  Furthermore,  micro VN tests sug 
gest  that  Ab2,2-17C3SCC  can substitute for  antigen 
in the induction of anti-polio neutralizing anti- 
bodies, and hence can function as a monoclonal 
anti-idiotypic  vaccine. 
In a number of systems, anti-idiotypic antibody (Ab2)' 
exogeneously administered  in animals  has been able  to 
replace antigen for the induction of specific immune 
responses by priming idiotype-positive, antigen-specific 
clones (1, 2). The most fascinating observation in this 
connection is the  demonstration  that immunization of 
mice against infection  with Trypanosoma rhodesiense 
could be accomplished by the administration of poly- 
clonal allogeneic Ab2 raised  against the idiotypes of a 
protective monoclonal antibody  with specificity for the 
major glycoprotein of a clone of this  parasite (3). In this 
system, the Ab2  did not appear to represent an  internal 
image of a parasite epitope, because the immunity in- 
duced by  Ab2 was genetically restricted (4). An example 
of Ab2 functioning as a true  internal image of external 
antigen  was reported by Leo et al. (5). who  demonstrated 
that  an anti-idiotypic antiserum  against antibodies  with 
specificity for Tobaco Mosaic virus  was  able  to  generate 
virus-specific antibodies  in  animals of several  species. 
In principle, however, the  use of polyclonal xenogeneic 
or allogeneic Ab2 preparations  for  this purpose has sev- 
eral disadvantages. First, it would be very difficult to 
establish production of polyclonal Ab2 preparations of 
high  consistency and identity.  Furthermore, a polyclonal 
Ab2 preparation will contain a heterogeneous population 
of anti-idiotypic  antibodies  in  which only a small  fraction 
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body; Ab2. antibody 2 or anti-idiotypic (-idiotope) antibody; Ab3. antibody 
' Abbreviations used in this paper: Abl, antibody 1 or  idiotypic anti- 
3; VN, vlrus neutralization: TCIDmo. tissue culture infection dose; SCC, 
single cell  cloned. 
induces idiotype-bearing molecules that will also bind 
antigen (3). Monoclonal  Ab2 possessing  a related epitope 
would represent  the ideal anti-idiotypic vaccine. On the 
other hand, the unique specificity of monoclonal Ab2 
could be a major drawback for its use as a vaccine, 
because such a vaccine will induce  antibody of unique 
epitope specificity. 
The  present  study  describes  the  induction of neutral- 
izing antibody  against poliovirus type I1 in mice  by treat- 
ment  with a syngeneic monoclonal Ab2. A series of mon- 
oclonal Ab2 was raised against various murine mono- 
clonal Ab1 with specificity for neutralization-inducing 
epitopes of the MEFl strain of poliovirus type 11 (6,  7). 
This poliovirus system  was  chosen  because the  assumed 
limited number of neutralization-inducing epitopes on 
polioviruses would overcome the theoretical  drawback of 
using monoclonal Ab2 as  a vaccine (8, 9). Furthermore. 
antibody mediated immunity is probably the major com- 
ponent of the protective immune  response  against  infec- 
tion. Additionally, we were able to demonstrate  that a 
single  inoculation of neutralizing  anti-poliovirus mono- 
clonal antibody could protect mice against a lethal  chal- 
lenge with live poliovirus (manuscript in preparation). 
The results of this study indicate primarily that Ab2- 
recognizing, paratope-related idiotopes of Ab1 are able to 
induce poliovirus-neutralizing antibodies in syngeneic 
animals without  antigen. 
MATERIALS AND METHODS 
Animals. BALB/c mice were purchased from the  Central Proefdi- 
eren Bedjif-TNO  (Zeist. The Netherlands). 
Antigens. Purified, ten-times  concentrated, inactivated polio vac- 
cines type I (Mahoney). type I1 (MEFl),  and type 111 (Saukett) were 
produced according to  standard  methods (1 0); they were the  gifts of 
Dr. A. L. van Wezel, National Institute of Public Health and Environ- 
mental Hygiene, Bilthoven, The Netherlands. 
Monoclonal antibodies. Monoclonal antibodies were produced ac- 
and modified as described by using  the P3-X63-&8.653 nonsecre- 
cording to  techniques initially developed by Kohler and Milstein (1 1) 
tor, HGPRT-deficient mouse myeloma cell line (1 2). Hybridomas were 
cloned twice by limiting dilutions  and were subsequently  single cell 
cloned (SCC)  by micromanipulation.  They were either propagated in 
syngeneic BALB/c mice as ascitic  tumors or in suspension  cultures 
clonal  anti-poliovirus  antibodies, also referred to as   Abl ,  have been 
in vitro. The production, selection. and  characterization of mono- 
raised against an Abl.l-lOC9E8 that was selected for its broad 
described (6. 7). Syngeneic monoclonal anti-idiotope antibodies were 
neutralization (VN) tests.  This  Abl.l-lOC9E8 (IgG2a.r] was purified 
reactivity with essentially all poliovirus type I1 strains in micro virus 
from ascitic fluid by affinity chromatography  on  protein A-Sepha- 
rose  (Pharmacia  Fine Chemicals,  Uppsala.  Sweden) (13). Five BALB/ 
c mice, 8 to 12 wk old. were  immunized by subcutaneous footpad 
injection with 75 pg of purified Abl, 1 -10C9E8 in complete Freund's 
adjuvant (Difco Laboratories, Detroit, MI), followed by multipoint 
dose subcutaneous booster  injection of 75 pg in incomplete Freund's 
adjuvant at day 14. Before the fusion of spleen cells with mouse 
myeloma cells on  day 34, mice received 50 p g  of purified Ab1,l- 
10C9E8 i.v. and i.p. on  days 28, 29, and 30. 
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Abl. ELISA plates  (Titertek  type 111: Flow Laboratories Inc.. McLean. 
ELISAfor t k  detection of cross-reactivities  with monoclonal 
VA] were coated with  150 pllwell of bovine anti-poliovirus  type 11, 
9.6. by incubation at  2OoC for 16 hr. Phosphate-buffered saline 
strain MEFl antibodies (45 M m l )  diluted in  carbonate  buffer, pH 
(PBS)-Tween 0.05% (Tween-80: Merck. Schuchardt, F.R.G.) was 
used for washing between each  step.  One  hundred microliters/well 
of 155s particles of poliovirus type 11, strain MEFl (50 d m l )  were 
added, and the plates were incubated a t  37OC for 2 hr. After  washing, 
BALB/c IgG2a.~ were  added to  the plates  and the  plates were incu- 
monoclonal anti-poliovirus  type I1 antibodies or control monoclonal 
bated for 2 hr   a t  20°C. The  plates were developed with  horseradish 
peroxidase-conjugated anti-poliovirus type 11 monoclonal Abl, 1 - 
10C9E8 and tetramethyl-benzidine substrate. The reaction was 
a Titertek  Multiskan (Flow Laboratories). 
stopped with 2 N &So4 (14). Absorbance at  450  nm  was read with 
Idiotype  cross-linking ELISA for  the  detection of monoclonal 
antf-fdfotope antibody. F(ab’), preparations were prepared from 
protein-A-Sepharose-purified Abl, 1-10C9E8 (lgG2a.~). control  mu- 
rine monoclonal IgG2a.x (Tl),  and Ab2.2-17C3SCC (IgG1)  by pepsin 
The solution was  adjusted to pH 3.8 with 0.1 N HCl. Fifty units of 
digestion. Purified IgG was dialyzed against saline overnight at 4°C. 
pepsin (Worthington Inc.. Cooper Biomedical. Malvern, PA) were 
added  per mg of  IgG. After incubation  at 37°C for 15 hr. the solution 
was adjusted to pH 8.0 with 0.1 N NaOH and  was dialyzed against 
ing  to Lowry et al. (1 5). The  extent of pepsin digestion was monitored 
saline overnight at 4OC. The protein content  was determined  accord- 
carbonate  buffer, pH 9.6, were incubated  in wells of microtiterplates 
by ELISA. Quantities of 150 pl of F(ab’), preparation  (10 pg/ml) in 
(Titertek type 111. Flow Laboratories) for 2 hr at 37°C. The  plates were 
washed  and  the  remaining binding sites were blocked as described 
below. F(ab’), was determined by peroxidase-conjugated sheep  anti- 
mouse Ig (Amersham, Inc., Buckinghamshire, England),  whereas  the 
undegraded I g G  remaining  was detected  with  peroxidase-linked  goat 
anti-mouse IgG. with  Fc  fragment-specific IgG. and  with protein-A 
(Pharmacia)  linked to peroxidase  (16). Plates were developed with 
tetramethyl-benzidine substrate,  and  the reaction was stopped with 
2 N HzsO4. Absorbance was  read at   450 nm  in a Titertek Multiskan 
(Flow Laboratories). In all of the F(ab’)z preparations used in  the 
present  study, undegraded IgG was  not detectable. 
F(ab’)z preparations of protein  A-Sepharose-purified Abl, 1- 
overnight onto micro ELISA plates (Titertek  type 111, Flow Laborato- 
10C9E8 or of control murine monoclonal IgG2a.x (Tl) were  bound 
ries) in  150 pllwell a t  a concentration of 0.5 to 3 pg/ml in carbonate 
buffer, pH 9.6, at 20°C. PBS-Tween (0.05% Tween-80) was used as 
were for 2 hr  at  37OC. Plates were washed between each  step by 
a diluent for subsequent  steps.  and  all  incubations  with  antibodies 
using a semi-automatic  washing device. Plates  were incubated with 
1% bovine serum albumin (Boseral, Organon Teknika, OSS. The 
sulted in low background  values.  Sixty  microliters of serial  dilutions 
Netherlands) between each step. This procedure consistently re- 
of hybridoma supernatant  fluids  containing monoclonal anti-Abl.1- 
10C9E8 idiotope antibody, referred to as Ab2, or protein A-Sepha- 
rose-purified Ab2 from supernatant  fluids were transferred  to  the 
Ab1 .l-lOCSE8-coated ELISA plates. Binding of Ab2 was detected 
after 2 hr by the addition of 100 rl of horseradish peroxidase (type 
VI: Sigma Chemical Company, St. Louis, M0)-coupled, protein A- 
Sepharose-purified Abl. 1-10C9E8 (16).  Plates were developed with 
tetramethyl-benzidine  substrate  and  the reaction was stopped  with 
2 N H,SO,. Absorbance was read at  450  nm by using a Titertek 
Multiskan automatic plate  reading machine [Flow Laboratories). 
Inhibition of idlotope  cross-lfnkfng ELISA for  detection of cross- 
reactive fdiotopes. The ability of neutralizing monoclonal antibodies 
guinea pigs, and  man immunized against poliovirus to  cross-react 
against poliovirus types I, 11, and I11 and of sera from rats, mice. 
with Ab2 was  tested by inhibition of the cross-linking of its homol- 
ogous idiotope. Abl, 1-1OC9E8. Two hundred microliters of a protein 
A-Sepharose-purified Ab2.2-17C3SCC at  a dilution giving 50% bind- 
ing in ELISA were incubated overnight with equal amounts of serial 
dilutions of the respective inhibitors. Monoclonal antibodies and 
sera used  in this  assay were  inactivated a t  56°C to avoid nonspecific 
binding, the  nature of which  is  at  present  unknown.  The  remaining 
anti-Ab1 activity of the  mixtures  was  assayed  in  the idiotope cross- 
linking ELISA as described. The percentage  inhibition was calcu- 
lated  according to  the formula: 
Percentage inhibition = 
OD 450  (uninhibited) - OD 450  (test) 
OD 450  (uninhibited) 
Detection of paratope-related fdfotopes. Inhibition of the binding 
of horseradish peroxidase-labeled Ab2.2- 17C3SCC (1 6) to  its homol- 
ogous plate-bound Abl. 1-10C9E8 by poliovirus was considered to 
be indicative for  site specificity of the Ab 1.1 - 1 OC9E8 idiotype. Serial 
dilutions of poliovirus types I, 11, or I11 were transferred  to  Abl.1- 
10C9E8 F(ab’)z-coated ELISA plates. Controls were performed by 
incubation  with  diluent without virus. After incubation,  100 pllwell 
of horseradish peroxidase-labeled Ab2,2-17C3SCC were  added. 
Plates were  finally developed as described. The percentage  inhibition 
was expressed as indicated above. 
Detection of Ab2.2-17CCSSCC-fnduced Ab3  in BALB/c mice. The 
sera of mice immunized with either Ab2.2-17C3SCC or normal 
BALB/c Ig were assayed  for  the  presence of a n  Ab3 reacting in a n  
the  same as described for  the Abl.l-lOC9E8 cross-linking ELISA. 
Ab2,2-17C3SCC cross-linking ELISA.  All conditions  were  essentially 
Plates were coated with 150 pllwell of Ab2.2-17C3SCC F(ab’)2. 
Mouse sera were  inactivated for 30 min at 56°C. Horseradish per- 
oxidase-labeled Ab2.2-17C3SCC at 100 pl/well was used to  test  the 
binding of Ab3 to plate-bound Ab2.2-17C3SCC F(ab’Iz. 
Assessment of neutralizing  anti-polfoufrus  antibodies. Micro- 
polio VN tests were carried  out  in flat-bottomed microtiter plates 
(Greiner  Laboratory Technik. Nurtingen. F.R.G.) by using 100 tissue 
culture infection  doses (TCIDm)  of poliovirus type lI/well, essentially 
as described (1 7). The  tests were  read 5 days  after inoculation. 
with  either  Abl.l-lOC9E8, Ab2.2-17C3SCC. or normal BALB/c I@. 
Mouse protection. Four- to 6-wk-old BALB/c mice were  inoculated 
The mice were inoculated i.p. with 0.5 ml protein A-Sepharose- 
purified Abl, 1-10C9E8  diluted in  saline.  This  preparation  has a titer 
of 104.’/50 pl when using 100 TCIDso in VN. The animals were 
challenged intracerebrally  24  hr  later by using 20 LD 50 of a mouse 
brain-adapted MEFl poliovirus type I1 strain. When treated with 
Ab2.2- 17C3SCC or normal BALB/c  IgG. mice were  challenged on day 
26. Animals  were  inoculated i.p. twice on  days 0 and 3. respectively, 
with 0.5 ml protein A-Sepharose-purified Ab2.2-17C3SCC (5 pg/ml) 
or normal BALB/c  IgG (5 pglml) diluted in  saline. 
RESULTS 
Monoclonal antibodies against polioviruses. Mono- 
clonal antibodies designated Ab1 were selected from a 
large panel  on the  basis of their broad reactivities  with 
poliovirus type I1 strains  as tested in the micro VN test 
(6, 7). Reaction patterns of these monoclonal antibodies 
in the VN test are shown in Table I. The  results suggested 
that these monoclonal antibodies react with the  same 
viral epitope. This was confirmed by the  observation that 
the binding of one monoclonal inhibits  the  binding of 
another to the  virus (Fig. 1). One of these monoclonal 
antibodies, Ab1 , 1-1 OC9E8, which has the isotype 
IgG2a,~, was used subsequently to generate syngeneic 
monoclonal Ab2 in BALB/c mice. 
Preparation of monoclonal Ab2. In three independent 
experiments, spleen cells of mice immunized against 
Ab1 .l-lOCSES were fused. Five clones were obtained 
that showed reactivities in the idiotope cross-linking 
ELISA. Culture supernatant fluids of these  hybridomas, 
TABLE I 
Intertypic and lntratypfc mfcro VN titers of antl-pollovlrus 
monoclonal antfbodles (Ab11 
Monoclonal Antlbodles 
Polloviruses 81/21 MEF 81/21 MEF 81/10 MEF 
1-10C9E8 4- 1 SD4E8  11E7 
Sabin 
SL 1881413 
NSL 8 1-4789 
NSL 77-728 
NSL 2 1 88 
NSL 77-686 
NSL 64-80 
T y p e 1  
Mahoney 
Sabin 
Type 111 
Saukett 
Sabfn 
781.250 
156.250 
3.906.250 
781.250 
781.250 
781.250 
3.906.250 
3.906.250 
<10 
< l o  
<10 
<lo 
781.250 
156.250 
3.906.250 
23.906.250 
23.906.250 
23.906.250 
23.906.250 
3.906.250 
< l o  
<lo 
<lo 
c10 
781.250 
6.250 
156.250 
156.250 
156.250 
156.250 
156.250 
156.250 
(10 
<10 
<10 
< I  0 
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1 c  
O !  
A 
OD 450nm 
5-1 5-2 5-3 5-4 5-5 5-6 5-7 5-8 5-9 5-10 
dtlutlon 
Figure 1. Inhibition of the binding of peroxidase-conjugated Abl, 1- 
1 OC9E8 to  plate-bound poliovirus type I1 by the homologous and two other 
heterologous monoclonal anti-poliovirus type I1 antibody preparations. 
SamplesAbl,l-1OC9E8(A).Abl,llE7[O).Ab1,4-15D4D8(A),andcontrol 
BALB/c IgG2a,~ (01 were  reacted  with  plate-bound poliovirus. as described 
in Materials  and Methods. Control EALBIc IgG2a.r. used as an inhibitor, 
resulted in OD 450  nm  values comparable with  values obtained  with PBS- 
Tween 0.95% as a n  inhibltor. 
cloned by limiting  dilution,  contained  antibody activity 
against idiotopes of Ab1 ,1-10C9E8, and none showed 
binding  to  normal BALB/c Ig-coated plates. Clone 2-  1 7C3, 
in  particular,  reacted  strongly  with Ab1 ,1-1 OC9E8, and 
appeared to be a stable producer.  2-  17C3 was recloned 
by manual isolation of single cells (SCC). Subsequent 
studies  were performed with F[ab’)z of protein A-purified 
culture  supernatant  fluids of Ab2,2-17C3SCC. the iso- 
type that  was found to be IgGl . The results of these 
experiments  show conclusively that Ab2.2-17C3SCC 
bound only to Ab1 , 1 -1 OC9E8 and not to control BALB/c 
IgGaa,~ (Fig. 2A). Furthermore, no binding of control 
BALB/c 1gGl to Ab1 , 1 - 1 OC9E8 or to control BALB/c 
IgG2a.~ was observed. 
Characterization of Ab2.2-17C3SCC. To determine 
whether Ab2.2- 17C3SCC was capable of interacting  with 
the Ab1 paratope-related idiotope, the inhibition of the 
horseradish peroxidase-conjugated Ab2,2-17C3SCC (1 6) 
to the purified F(ab’In of Ab1 ,1-10C9E8 by poliovirus 
types I, 11, and 111 was  carried  out.  Figure 2 8  shows  that 
binding could indeed be  inhibited by 5 pg of intact 155s 
particles of poliovirus type 11, whereas  comparable 
amounts of 155s particles of poliovirus types I or 111 did 
not affect the binding of Ab2,2-17C3SCC to ABl.1- 
lOC9E8. Although on the  basis of these  results  the pos- 
sible  influence of steric  hindrance  cannot be ruled out 
completely, the  data suggest that Ab1 , 1 - 1 OC9E8 possess 
a paratope-related idiotope with complementarity for 
Competitive inhibition  studies were also  carried  out  to 
determine whether Ab2,2-17C3SCC could recognize a 
structure uniquely  associated  with Ab 1.1 - 1 OC9E8 or a 
cross-reactive determinant. The results are shown in 
Figure 2C. Preincubation of Ab2.2-17C3SCC with its ho- 
mologous  Ab1 ,I - 1 OC9E8 idiotope produced a dose-related 
inhibition pattern  in  the idiotope cross-linking ELISA, as 
did two other anti-poliovirus type I1 monoclonal anti- 
bodies. Other  anti-poliovirus  type I, 11, and 111 monoclonal 
antibodies and a control monoclonal antibody (IgGaa,~] 
Ab2,2- 17C3SCC. 
dtlutlon 
C 
lnhibltlon 
B 
% inhlbitlon 
1 oc 
50 
C 
D 
O h  lnhlbltton 
’O0r 
5-3 5-2 5 -1 dtlutlon 0 
F(ab’), of protein A-purified supernatant fluids of anti-idiotope-producing 
Figure 2. [A) Detection of anti-idiotope in idiotope cross-linking ELISA. 
hybridoma cell line 2-17C3SCC [0) or control BALB/c IgG2a.~ [A) were 
incubated on ELISA plates coated with either idiotope Abl.l-lOC9E8 
(open symbols) or control BALB/c  IgG2a,x [closed symbols). Plates were 
additionally developed with the horseradish peroxidase-labeled idiotope 
Abl.l-10C9E8. Similar results were obtained in seven separate experi- 
horseradish peroxidase-labeled anti-idiotope 2-1 7C3SCC  to plate-bound 
ments. (B) Detection of paratope-related idiotope. Inhibition of binding of 
idiotope 1-10C9E8 by poliovirus type I(O], type 11 (A]. and type I11 0. Data 
are presented as the  mean f SE of triplicate  determinations. [C) Detection 
of cross-reactive idiotope. Inhibition of idlotope cross-llnking ELlSA by 
incubation of anti-idiotope 2- 17C3SCC with  neutralizing anti-poliovirus 
type 11 monoclonal antibodies: 1-1 OC9E8 (0). 1  1 E7 (A]. 4- 15D4D8 m. or 
other monoclonal antibodies: and nonneutralizing  anti-poliovirus  type I1 
I11 (V), and control BALB/c IgG2a.r $3. Similar results were obtained in 
(0). neutrallzinganti-poliovirus type I (a).  neutralking anti-poliovirus type 
three  separate experiments. [D) Detection of interspecies cross-reactive 
idiotopes. Inhibition of idiotope cross-linking ELISA by incubation of anti- 
idiotope 2-1703 with  anti-poliovirus  type I1 hyperimmune sera (closed 
symbols) of rats [A). guinea pigs 0. mice (0). and  humans (T), or  their 
respective  prelmmune sera (open symbols). One panel of representative 
data  is given from  experiments  in which sera were tested from six rats, 
two guinea pigs, 12 mice. and  12  humans. 
failed to inhibit the binding of Ab2,2-l7C3SCC to its 
homologous  idiotope  Ab1 , 1 - 1 OC9E8  [Fig. 2C). These  re- 
sults suggest that Ab2,2-17C3SCC may identify a cross- 
reactive idiotope. In experiments  with the  use of Ab2,2- 
17C3SCC as a probe to  screen  conventional poliovirus- 
neutralizing antisera of several species including man, 
evidence was  obtained that Ab2,2-17C3SCC detects an 
interspecies  cross-reactive idiotope. The  results of these 
experiments are depicted in Figure 20. Cross-linking of 
Ab1 , 1 - 1 OC9E8 by  Ab2.2-  17C3SCC  could be inhibited by 
previous incubation of Ab2,2-17C3SCC with the  sera of 
poliovirus type 11-immune rats, mice, guinea pigs, and 
humans. Preimmune sera showed no  inhibition in  this 
assay.  The reactivity of monoclonal Ab2 with immune 
sera from different  species including humans  can also 
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be interpreted  to  mean that  these molecules possess a 
true  internal image of a viral epitope (2, 18, 19). 
Generation of Ab3 in BALB/c mice by immunization 
with Ab2.2-17C3SCC. Because Ab2,2-17C3SCC possibly 
bears a poliovirus-related epitope. experiments were per- 
formed to  induce protective immunity  against poliovirus 
by immunizing mice with different doses of Ab2.2- 
17C3SCC. Screening of sera from mice after Ab2,2- 
17C3SCC treatment  but before challenge with poliovirus 
revealed evidence for the presence of Ab3 in all sera 
tested  in the Ab2.2-17C3SCC cross-linking ELISA (Table 
11). The  sera of control mice that had  been  treated  with 
the protein  equivalent of normal BALB/c  IgG showed no 
detectable reactivity. The  antigen-binding  capacity of all 
sera  was investigated by using  the micro VN assay. As 
shown  in  Table 11, four of eight mice, all  expressing Ab3 
after Ab2.2-17C3SCC treatment, were able  to  neutralize 
the MEFl strain of poliovirus type 11. The  sera of control 
mice did not  exert  neutralizing activity. Taken  together, 
these  results  strongly  indicate that  treatment of  BALB/c 
mice with Ab2.2- 17C3SCC induced the expression of the 
Ab 1, l -  1 OC9E8 idiotope. 
Although Ab2.2-17C3SCC was capable of inducing 
poliovirus-neutralizing antibody  in mice, it failed to pro- 
tect BALB/c mice against a lethal challenge with the 
MEFl strain of poliovirus type 11. In contrast, a single 
inoculation of Ab1 ,1-10C9E8  in BALB/c mice proved to 
be protective against  a  lethal  challenge  with poliovirus 
(Table 11). The relatively low levels of serum-neutralizing 
antibody  in  Ab2,2- 17C3SCC-treated mice as compared 
with Ab1 , 1 - 1 OCSE8-treated animals may explain this 
observation.  Studies are in progress to improve the im- 
TABLE I1 
Antt-tdtotype 2-1 7C3SCC tnduces  expresslon of neutralking 1 - 
10CSEB-related  tdlotypes 
Expresslon 
Mlce lnofulated wlth Number of Survivalb after 
Dilutlon of ~f~~ Idlotope" Neutrallzing Challenge 
(OD 450 nm) antibody 
2-17C3SCC anti-id' 
10 
lo-' 
10-2 
10-3 
Normal  BALB/c Ig 
1-10C9E8 idb 
10 
lo-' 
10-2 
10-3 
None 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
0.477 
1.635 
0.594 
0.931 
0.341 
0.61 1 
0.209 
0.178 
0.107 
0.119 
NDd 
ND 
ND 
ND 
ND 
32 
32 
>2 
>2 
>2 
5 
10 
10 
11 
9 
12 
8 
7 
9 
10 
>4096  >25 
>4096 
>25 
;ii >25 
8 15 
2  13 
<2  14 
<2  9 
bound Ab2.2-17C3SCC with HRPO-labeled Ab2.2-17C3sCC in ELISA. 
a Sera of lndividual  mice  were assayed for the abillty  to cross-link plate- 
a neutrallzation  titer of 104.'/50 pl when using 100 TCIDm: 0.5 ml  of the 
The  idiotope 1-10C9E8 was used as proteln  A-purified  material  with 
respective dilutions was inoculated  in  indlvldual  mice 24 hr  before chal- 
lenge  wlth 20 LDJoof  poliovirus  type 11, strain MEFl. 
from  hybridoma supernatant fluid  with a protein content of 5 p g h l .  Mlce 
'The antl-ldlotype 2-17C3SCC was a protein A-purified preparation 
were  Injected with 0.5 ml antl-id In sallne twlce. Animals  were  challenged 
on day 6. 
ND = not  determlned. 
mune response to Ab2.2-17C3SCC in mice by using 
newly developed methods of antigen  presentation. 
DISCUSSION 
We have  demonstrated that immunization of mice with 
a monoclonal syngeneic Ab2.2-17C3SCC directed against 
a neutralizing anti-poliovirus type I1 monoclonal anti- 
body.  Ab1 ,I-1 OC9E8, without  antigen,  induces an Ab3 
response, of which at least part  consists of a population 
of antibody that shares two properties with Ab1 ,1- 
10C9E8: the binding of poliovirus type I1 strain MEFl 
(Table 11) and  the binding  to Ab2,2-17C3SCC (Table 11). 
Ab2,2-17C3SCC defines not only a paratope-related idi- 
otope on Ab 1,l-  10C9E8 but  also idiotopes on two other 
neutralizing  anti-poliovirus type I1 monoclonal antibodies 
(Fig. 2C). This  finding is in agreement  with the  results of 
the inhibition  studies  shown in Figure 1, which indicate 
that all  three neutralizing monoclonal antibodies  react 
with the  same epitope on poliovirus type 11. Thus, Ab2,2- 
17C3SCC probably defines  a IdX that constitutes a major 
component of the  immune response of mice to poliovirus 
type 11. Tesch et al. (20)  and Takemori et al. (21) suggested 
that if Ab2 recognizes an idiotope on Ab1 that is formed 
by many germline-encoded VH-D-V~ combinations, im- 
munization  with Ab2  would induce  antibodies that  are 
idiotypically related to Ab1 preferentially. In addition, 
these  authors emphasized that immunization  with Ab2 
recognizing a  paratope-related idiotope would generate 
antibodies that  are indistinguishable from Ab1 also  in 
terms of antigen binding. Therefore, it is reasonable  to 
assume that the paratope-related idiotope of Abl, 1- 
10C9E8 is encoded by VH and VL germline genes.  The 
outcome of immunization with Ab2.2-17C3SCC is in 
agreement  with this assumption. 
On the  other  hand.  the screening of hyperimmune sera 
from several  species  (including  man) revealed a striking 
association between the Ab2,2-17C3SCC-binding idi- 
otope and poliovirus type 11-specific antibody (Fig. 20). 
Such an  association that is related to the  present reactiv- 
ity of Ab2 with Ab1 from different species could be 
interpreted as  interspecies idiotope cross-reactivity. The 
existence of interspecies idiotype cross-reactivity has 
been reported in  the  murine GAT idiotype (22-24) and 
the T15 idiotype (25). as well as in the human CHBs 
idiotype (26) system. This interspecies idiotype cross- 
reactivity has been explained on the  basis of a common 
VH germline  gene coding for IdX that  has been maintained 
through extended periods of evolution (22,  24-26). 
However, the interspecies reactivity (as in  the  case of 
Ab2,2-  17C3SCC and Ab 1.1 - 1 OC9E8) might also reflect 
that a related epitope, i.e., internal image, is present  (1, 
2,18,19). Whatever the  actual mechanism is, the  present 
results  are  important  in  terms of an anti-idiotypic vaccine 
that is monoclonal, and  hence predictable and available 
in large quantities. Furthermore, in terms of internal 
image such an anti-idiotypic vaccine  against viral infec- 
tion could be  useful  in any species. 
The  generation of idiotypic antibody of predefined an- 
tigen specificity by immunization with Ab2 in  the  ab- 
sence of antigen has been reported for a number of 
experimental systems (3, 5, 27-31). Recently Ertl and 
Finberg (32) reported the induction of a protective cyto- 
lytic T cell response in mice against a  lethal  Sendai virus 
ANTI-IDIOTYPIC-INDUCED POLIOVIRUS NEUTRALIZING ANTIBODY 1229 
infection by preimmunization of mice with a monoclonal 
anti-idiotypic  antibody  directed  against a Sendai  virus- 
specific  helper  T cell clone. To our knowledge, this is the 
first report  demonstrating that monoclonal Ab2 can be 
used to induce specific virus-neutralizing antibody re- 
sponses. 
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